中文 | English
Return
Total: 156 , 1/16
Show Home Prev Next End page: GO
Author:( ZHANG Qiming)

1.Comparison of efficacy and safety of mizoribine and mycophenolate mofetil in kidney transplant recipients: a single-center retrospective study

Xinji YANG ; Weilong SHI ; Zaiwei SONG ; Zhifei XIE ; Herong ZHU ; Wenbin ZHANG ; Hongxian ZHANG ; Lei LIU ; Lei ZHAO ; Lu WANG ; Zhidan WANG ; Shudong ZHANG ; Qiming ZHANG ; Xiaofei HOU

Organ Transplantation 2026;17(4):625-634

2.Correlation analysis between CT equipment and socio economic development situation in medical institutions of various grade and classification in Jiangsu province

Jiaming LU ; Qiming DENG ; Xiang LI ; Xin ZHANG ; Zhengge WANG ; Ming LI ; Ximing WANG ; Cheng LI ; Bing ZHANG ; Chunhong HU

China Medical Equipment 2025;22(3):97-101

3.Correlation analysis between CT equipment and socio economic development situation in medical institutions of various grade and classification in Jiangsu province

Jiaming LU ; Qiming DENG ; Xiang LI ; Xin ZHANG ; Zhengge WANG ; Ming LI ; Ximing WANG ; Cheng LI ; Bing ZHANG ; Chunhong HU

China Medical Equipment 2025;22(3):97-101

4.Analysis of Coordination Strategies with ICH Q3C for Residual Solvent Control in Pharmacopoeia of Various Countries

Min CHEN ; Weicong WU ; Xinyi XU ; Suming WANG ; Xiao LING ; Qiming ZHANG ; Ying CHEN ; Lei CHEN

Herald of Medicine 2025;44(2):227-235

5.Exploration on the Effects of Yiqi Huoxue Huazhuo Jiedu Prescription on Cerebral Ischemia Reperfusion Injury in Rats Based on PERK/ATF4 Signaling Pathway

Tiantian XU ; Ye TIAN ; Shiduo WANG ; Jiayun ZHANG ; Qiming LIU ; Zhe ZHANG ; Xi LI ; Junbiao TIAN

Chinese Journal of Information on Traditional Chinese Medicine 2025;32(7):81-87

6.Additions and revisions of general chapters of physical and chemical analysis in the Chinese Pharmacopoeia 2025 Edition Volume Ⅳ

XU Xinyi ; WEI Shifeng ; ZHANG Qiming ; HE Langchong ; ZHANG Jun ; MA Shuangcheng

Drug Standards of China 2025;26(1):045-050

7.Additions and revisions of general chapters of physical and chemical analysis in the Chinese Pharmacopoeia 2025 Edition Volume Ⅳ

Xinyi XU ; Shifeng WEI ; Qiming ZHANG ; Langchong HE ; Jun ZHANG ; Shuangcheng MA

Drug Standards of China 2025;26(1):45-50

8.Safety and efficacy of hepatic arterial infusion chemotherapy using second-line lenvatinib plus immune checkpoint inhibitors in the treatment of progressive advanced hepatocellular carcinoma

Qiming WEI ; Sheng ZHONG ; Haiming ZHANG ; Hong ZHANG ; Fengtao ZHANG

Journal of Interventional Radiology 2025;34(3):261-267

9.Hepatic arterial infusion chemotherapy combined with apatinib and carizolizumab for hepatocellular carcinoma with major portal vein tumor thrombosis:analysis of its safety and efficacy

Shugui HUANG ; Qiming WEI ; Fengtao ZHANG

Journal of Interventional Radiology 2025;34(9):1002-1009

10.Research progress on the relationship between vascular structure patterns and prognosis of renal cell carcinoma

Dameng PAN ; Qiming ZHANG ; Min QIU ; Lulin MA

Journal of Modern Urology 2025;30(3):261-265

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 156 , 1/16 Show Home Prev Next End page: GO